Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -207.95M | -986.58M | -1.01B | -1.02B | -1.03B |
| Total Depreciation and Amortization | 221.58M | 218.37M | 217.26M | 214.98M | 214.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 355.98M | 1.09B | 1.11B | 1.08B | 1.08B |
| Change in Net Operating Assets | 121.83M | 62.54M | -13.24M | 50.36M | -56.01M |
| Cash from Operations | 491.44M | 386.81M | 305.61M | 323.66M | 210.54M |
| Capital Expenditure | -134.66M | -139.73M | -135.99M | -129.51M | -135.99M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -75.00M | 0.00 | -45.00M | -45.00M | -45.00M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 404.78M | 201.86M | 247.86M | -130.64M | -261.17M |
| Cash from Investing | 195.12M | 62.13M | 66.87M | -305.15M | -442.16M |
| Total Debt Issued | -- | 0.00 | 0.00 | 266.75M | 266.75M |
| Total Debt Repaid | -249.17M | -249.17M | -249.17M | -50.00M | -50.00M |
| Issuance of Common Stock | 28.58M | 28.95M | 30.87M | 34.24M | 34.24M |
| Repurchase of Common Stock | -129.00K | -129.00K | -129.00K | -1.37M | -1.37M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -117.36M | -31.37M | -31.99M | -270.92M | -17.75M |
| Cash from Financing | -338.09M | -251.72M | -250.41M | -21.30M | 231.87M |
| Foreign Exchange rate Adjustments | 891.00K | -2.86M | -984.00K | -1.86M | -3.29M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 349.36M | 194.37M | 121.08M | -4.66M | -3.04M |